Contract 75N94020F00001
Boston Medical Center Corporation · Department Of Health And Human Services · September 24, 2020
Boston Medical Center Corporation was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 24, 2020 for $4.95 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Boston, MA. This is a task or delivery order issued under parent IDIQ 75N94020D00004. It was awarded under a small business set-aside. The contract has been modified 84 times since the base award It uses cost no fee contract pricing. The most recent modification was on March 25, 2026.
Contract details
- PIID
- 75N94020F00001
- Parent IDIQ
- 75N94020D00004
- Award type
- Delivery Order
- Pricing
- Cost No Fee
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Boston, MA
- First action
- September 24, 2020
- Latest action
- March 25, 2026
Description
NICHD: R&D: TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES: SEVERABLE
Modification timeline
-
March 25, 2026Mod P00010 · Funding Only Action$54.0K
-
September 29, 2025Mod P00002 · Funding Only ActionNICHD: R&D: CHEMICAL SCREENING AND OPTIMIZATION FACILITY - SCALABLE QUANTITIES OF ACTIVE PHARMACEUTICAL INGREDIENTS: SEVERABLE$369.0K
-
September 22, 2025Mod P00007 · Other Administrative ActionNICHD: R&D: CORE FUNCTION ACTIVITIES: SEVERABLE$72.7K
-
September 22, 2025Mod P00008 · Exercise An OptionNICHD: R&D: CORE FUNCTION ACTIVITIES: SEVERABLE$72.7K
-
September 22, 2025Mod P00009 · Other Administrative ActionNICHD: R&D: CCTN CORE FUNCTION ACTIVITIES: SEVERABLE$220.0K
-
September 18, 2025Mod P00007 · Other Administrative ActionNICHD: R&D: 75N9420D00003 - BIOLOGICAL TESTING FACILITY: TASK ORDER 1: ADMINISTRATIVE/MANAGEMENT - SRI INTERNATIONAL: SEVERABLE$2.57M
-
September 11, 2025Mod P00006 · Funding Only ActionNICHD: R&D: 75N9420D00003 - BIOLOGICAL TESTING FACILITY: TASK ORDER 1: ADMINISTRATIVE/MANAGEMENT - SRI INTERNATIONAL: SEVERABLE$2.57M
-
September 10, 2025Mod P00002 · Funding Only ActionNICHD: R&D: NEWBORN SCREENING PILOT STUDY FOR AN EXPANDED GROUP OF HOMOCYSTINURIA (HCU)-RELATED DISORDERS (TERMED "EXPANDED HCU"): NON-SEVERABLE$783.5K
-
September 4, 2025Mod P00003 · Other Administrative ActionNICHD:R&D:DATA COORDINATING CENTER FOR SPROUTS AGES 6- AND 7- YEARS ASSESSMENTS AND STUDY CLOSEOUT:NON-SEVERABLE$519.9K
-
September 4, 2025Mod P00007 · Funding Only ActionNICHD: R&D: TIME AIM OF THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN): NON-SEVERABLE$859.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N94020F00001?
Contract 75N94020F00001 is a federal contract awarded to Boston Medical Center Corporation by Department Of Health And Human Services on September 24, 2020 for $4.95 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 84 times since the base award.
Who won contract 75N94020F00001?
Boston Medical Center Corporation won contract 75N94020F00001 from Department Of Health And Human Services.
How much is contract 75N94020F00001 worth?
Contract 75N94020F00001 has obligated $4.95 million to date.